UPDATE: Myriad Genetics Submits Premarket Approval to FDA for BRACAnalysis(R)
April 07, 2014 at 16:31 PM EDT
Myriad Genetics (Nasdaq: MYGN) today announced that it has submitted the first module of a premarket approval (PMA) application to the ...